Relay Therapeutics, Inc.

NasdaqGM:RLAY 주식 보고서

시가총액: US$795.1m

Relay Therapeutics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

NasdaqGM:RLAY 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
28 Oct 24SellUS$10,284Thomas CatinazzoIndividual1,697US$6.06
28 Oct 24SellUS$9,823Peter RahmerIndividual1,621US$6.06
28 Oct 24SellUS$9,890Brian AdamsIndividual1,632US$6.06
28 Oct 24SellUS$16,289Donald BergstromIndividual2,688US$6.06
27 Sep 24SellUS$4,866Donald BergstromIndividual648US$7.51
27 Sep 24SellUS$2,215Brian AdamsIndividual295US$7.51
27 Sep 24SellUS$2,215Thomas CatinazzoIndividual295US$7.51
27 Sep 24SellUS$1,840Peter RahmerIndividual245US$7.51
29 Jul 24SellUS$14,496Brian AdamsIndividual1,638US$8.85
29 Jul 24SellUS$23,877Donald BergstromIndividual2,698US$8.85
29 Jul 24SellUS$12,027Peter RahmerIndividual1,359US$8.85
29 Jul 24SellUS$15,063Thomas CatinazzoIndividual1,702US$8.85
27 Jun 24SellUS$1,847Brian AdamsIndividual295US$6.26
27 Jun 24SellUS$1,847Thomas CatinazzoIndividual295US$6.26
27 Jun 24SellUS$1,534Peter RahmerIndividual245US$6.26
27 Jun 24SellUS$4,056Donald BergstromIndividual648US$6.26
03 Jun 24SellUS$128,520Peter RahmerIndividual19,864US$6.47
29 Apr 24SellUS$17,137Donald BergstromIndividual2,686US$6.38
29 Apr 24SellUS$10,814Thomas CatinazzoIndividual1,695US$6.38
29 Apr 24SellUS$10,355Brian AdamsIndividual1,623US$6.38
29 Apr 24SellUS$8,581Peter RahmerIndividual1,345US$6.38
27 Mar 24SellUS$2,295Peter RahmerIndividual298US$7.70
27 Mar 24SellUS$2,680Brian AdamsIndividual348US$7.70
27 Mar 24SellUS$5,891Donald BergstromIndividual765US$7.70
27 Mar 24SellUS$2,680Thomas CatinazzoIndividual348US$7.70
29 Jan 24SellUS$19,328Thomas CatinazzoIndividual2,005US$9.64
29 Jan 24SellUS$15,916Peter RahmerIndividual1,651US$9.64
29 Jan 24SellUS$18,596Brian AdamsIndividual1,929US$9.64
29 Jan 24SellUS$30,636Donald BergstromIndividual3,178US$9.64
27 Dec 23SellUS$3,384Brian AdamsIndividual294US$11.51
27 Dec 23SellUS$11,245Donald BergstromIndividual977US$11.51
27 Dec 23SellUS$3,384Thomas CatinazzoIndividual294US$11.51
27 Dec 23SellUS$2,808Peter RahmerIndividual244US$11.51

내부자 거래량

내부자 구매: RLAY insiders는 지난 3개월 동안 주식만 판매했습니다.

소유권 분석

RLAY 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
공공 기업4,5800.00274%
일반 대중2,654,6731.59%
개인 내부자2,873,6171.72%
VC/PE 기업37,156,07122.2%
교육기관124,694,01774.5%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 35.8% 만큼 증가했습니다.

최대 주주

상위 25 주주가 회사의 75.4%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
16.7%
SB Investment Advisers (UK) Limited
27,904,963US$132.5m0%0.69%
8.64%
The Vanguard Group, Inc.
14,463,614US$68.7m23.6%데이터 없음
7.02%
BlackRock, Inc.
11,742,147US$55.8m11.4%데이터 없음
5.53%
Casdin Capital, LLC
9,251,108US$43.9m9.5%2.78%
4.41%
Bellevue Asset Management AG
7,377,184US$35.0m15.7%0.41%
3.16%
JP Morgan Asset Management
5,286,019US$25.1m41.4%데이터 없음
3.15%
T. Rowe Price Group, Inc.
5,280,291US$25.1m4.79%데이터 없음
2.57%
State Street Global Advisors, Inc.
4,300,216US$20.4m1.22%데이터 없음
2.3%
Nextech Invest Ltd.
3,846,409US$18.3m0%2.6%
2.13%
Tang Capital Management, LLC
3,568,058US$16.9m0%1.24%
2.09%
Braidwell LP
3,499,427US$16.6m16.4%0.72%
1.98%
Norges Bank Investment Management
3,319,342US$15.8m0%데이터 없음
1.74%
Citadel Advisors LLC
2,909,371US$13.8m150%0.01%
1.63%
Geode Capital Management, LLC
2,732,270US$13.0m15.5%데이터 없음
1.6%
Eventide Asset Management, LLC
2,682,083US$12.7m0%0.21%
1.49%
EcoR1 Capital, LLC
2,500,000US$11.9m0%0.41%
1.21%
BioImpact Capital LLC
2,033,041US$9.7m59.5%1.52%
1.09%
Walleye Capital LLC
1,819,983US$8.6m6,660%0.06%
1.09%
Tavistock Life Sciences
1,819,132US$8.6m0%0.55%
1.04%
Dimensional Fund Advisors LP
1,748,663US$8.3m15%데이터 없음
1.04%
Point72 Asset Management, L.P.
1,736,517US$8.2m0%0.02%
0.99%
Adage Capital Management, L.P.
1,650,000US$7.8m0%0.01%
0.97%
Finepoint Capital LP
1,626,146US$7.7m1.3%0.83%
0.93%
GV Management Company, LLC
1,564,173US$7.4m0%0.44%
0.92%
First Light Asset Management, LLC
1,542,406US$7.3m0%0.62%